Versant Venture Capital Vi, L.P. Monte Rosa Therapeutics, Inc. (GLUE) insider trading activity

Versant Venture Capital Vi, L.P. is of Monte Rosa Therapeutics, Inc.. Currently has a direct ownership of 4.08 Million shares of GLUE, which is worth approximately $29.1 Million. The most recent transaction as insider was on Oct 28, 2024, when has been sold 1,019,867 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.08M

20.0% 3M change

40.0% 12M change

Total Value Held $29.1 Million

Versant Venture Capital VI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 28 2024	SELL Other acquisition or disposition	-	1,019,867 Reduced 20.0%	4,079,469 Common Stock
Sep 20 2024	SELL Open market or private sale	$7,395,655 $6.53 p/Share	1,132,566 Reduced 18.17%	5,099,336 Common Stock
Sep 13 2024	SELL Open market or private sale	$57,097 $6.16 p/Share	9,269 Reduced 0.15%	6,231,902 Common Stock
Sep 12 2024	SELL Open market or private sale	$96,282 $6.0 p/Share	16,047 Reduced 0.26%	6,241,171 Common Stock
Sep 11 2024	SELL Open market or private sale	$3,251,382 $6.0 p/Share	541,897 Reduced 7.97%	6,257,218 Common Stock
Jun 28 2021	BUY Conversion of derivative security	-	6,515,869 Added 48.94%	6,799,115 Common Stock

Also insider at

BDTX

Black Diamond Therapeutics, Inc. Healthcare

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

OYST

Oyster Point Pharma, Inc. Healthcare

> 10% Shareholder

IPSC

Century Therapeutics, Inc. Healthcare

> 10% Shareholder

GRPH

Graphite Bio, Inc. Healthcare

CTNM

Contineum Therapeutics, Inc.

> 10% Shareholder

TPST

Tempest Therapeutics, Inc. Healthcare

VVC